Drug
Daunorubicin citrate clinical trials
A product of Daunorubicin; its studies count on that page too.
Includes 9 studies of Liposomal Daunorubicin Citrate.
Studies by the year they started
9 studies that test it; most in 1997 (1)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 9
University of Birmingham (1) · Massachusetts General Hospital (1) · University Hospital Schleswig-Holstein (1) · National Cancer Institute (NCI) (1) · Dutch Childhood Oncology Group (1) · Gruppo Italiano Malattie EMatologiche dell'Adulto (1) · AIDS Malignancy Consortium (1) · University of Leicester (1)
Often tested with
Tested in the same studies.
Fludarabine (2) · Cytarabine (2) · Busulfan (2) · Etoposide (2) · Gemtuzumab (1) · Idarubicin (1) · Venetoclax (1) · Azacitidine (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Daunorubicin
Studies
Open first, then newest update. How each study uses daunorubicin citrate is read from its arms, and is right about nine times in ten.
Testing it · 9
- International Randomised Phase III Clinical Trial in Children With Acute Myeloid LeukaemiaActive, not recruitingPhase 3University of BirminghamNCT02724163Written as Liposomal daunorubicin
- Venetoclax + Azacitidine vs. Induction Chemotherapy in AMLActive, not recruitingPhase 2Massachusetts General HospitalNCT04801797Written as Liposomal daunorubicin and cytarabine
- International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic LeukemiaCompletedPhase 3University Hospital Schleswig-HolsteinNCT01117441Written as daunoxome
- Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's SarcomaTerminatedPhase 1AIDS Malignancy ConsortiumNCT00427414Written as liposomal daunorubicin citrate
- Liposomal Daunorubicin in Treating Patients With Metastatic Breast CancerStatus unknownPhase 1University of LeicesterNCT00004207Written as liposomal daunorubicin citrate
- Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial TherapyCompletedPhase 1/2National Cancer Institute (NCI)NCT00005942Written as liposomal daunorubicin citrate
- Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and AdolescentsStatus unknownPhase 2/3University Hospital MuensterNCT00111345Written as liposomal daunorubicin
- Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid LeukemiaCompletedPhase 3Dutch Childhood Oncology GroupNCT00186966Written as Fludarabine, Cytarabine, Liposomal daunorubicin (DaunoXome)
- DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AMLCompletedPhase 3Gruppo Italiano Malattie EMatologiche dell'AdultoNCT00589082Written as DaunoXome
Given in every arm · 1 — daunorubicin citrate is usual care beside what is tested
Codes
What other systems call daunorubicin citrate · ClinicalTrials.gg INT015086
- UNII (FDA) 5L84T2Z6NPDAUNORUBICIN CITRATEConfirmed FDA, Wikidata
- RxNorm 221087Confirmed FDA, Wikidata
- Wikidata Q27262517daunorubicin citrateConfirmed FDA, Wikidata
- NCI Thesaurus C47471Daunorubicin CitrateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5L84T2Z6NP | DAUNORUBICIN CITRATE | Confirmed FDA, Wikidata |
| RxNorm | 221087 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27262517 | daunorubicin citrate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C47471 | Daunorubicin Citrate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.